Product Images Meclizine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Meclizine Hydrochloride NDC 67296-1849 by Redpharm Drug, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - image 01

Structure - image 01

logo - image 02

logo - image 02

Label-12.5 mg - image 03

Label-12.5 mg - image 03

NDC 62559-841-01 is a prescription medicine in the form of Meclizine Hydrochloride USP Tablets. Each tablet contains 12.5 mg meclizine dihydrochloride equivalent to 10.58 mg of meclizine free base. It is used for VERTIGO and the recommended dosage should be determined by a healthcare professional. It should be dispensed in a tight, light-resistant container and stored within a controlled room temperature. This medicine should be kept out of the reach of children. It is manufactured by ANI Pharmaceuticals Canada, Inc. and distributed by ANI Pharmaceuticals, Inc.*

Label-25 mg - image 04

Label-25 mg - image 04

NDC 62559-842-01 Meclizine Hydrochloride Tablets USP is a prescribed medication used for the treatment of vertigo. The medication comes in 100 tablets containing 25 mg of meclizine dihydrochloride. The dosage is determined by clinical response but is usually between 25 mg to 100 mg per day. The medication should be kept out of reach of children and stored in a tight, light-resistant container as defined in the USP. ANI Pharmaceuticals Canada manufactures, and ANI Pharmaceuticals Inc. distributed it.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.